Topic: Cardiac rehabilitation Purpose: We have recently reported that 12-week cardiac rehabilitation (CR) initiated early after balloon pulmonary angioplasty (BPA) ameliorates exercise capacity close to normal level in patients with inoperable chronic thromboembolic pulmonary hypertension (CTEPH), without deterioration in pulmonary haemodynamics or right-sided heart failure (HF). However, it remains unknown whether near-normal exercise capacity recovered by CR following BPA will be sustained or gradually deteriorate. Thus, the aim of this study was to fully elucidate the time course of combined effects of BPA and subsequent CR on exercise capacity up to one year after. Methods: We prospectively enrolled 48 consecutive patients (mean age, 67AE11 years; 35 women) with inoperable CTEPH who underwent a series of BPA (4.0AE1.8 procedures). Early after the final BPA (6.4AE2.7 days), 19 out of 48 patients participated in 12-week CR programme, which included walking, bicycle ergometer, and low-intensity resistance training of the lower limbs and consisted of 1-week in-hospital training and following 11-week outpatient programme under close supervision. Serial changes of cardiopulmonary exercise testing and right heart catheterisation were assessed before the first BPA, after the final BPA (the beginning of CR), at the end of CR, and one year after the end of CR. Results: In 48 patients, BPA significantly improved pulmonary haemodynamics to a level below the definition of pulmonary hypertension (mean pulmonary arterial pressure [mPAP], from 35AE11 to 24AE6 mmHg), right-sided HF (World Health Organization functional class [WHO-FC], from 2.6 to 2.2), exercise intolerance (normalised peak oxygen uptake [VO2], from 63AE12 to 72AE12%), and ventilatory efficiency (ventilatory response to carbon dioxide production [VE-VCO2 slope], from 44AE9 to 37AE8), without major complications (all P<0.05). After 12-week CR (n=19), residual exercise intolerance (normalised peak VO2, from 69AE9 to 78AE13%), ventilatory efficiency (VE-VCO2 slope, from 39AE9 to 36AE7), quadriceps strength, and HF symptoms (WHO-FC, from 2.1 to 1.8) further improved (all P<0.05), with maintaining pulmonary haemodynamics (mPAP, from 24AE6 to 25AE5 mmHg). The near-normal exercise capacity was sustained even one year after the end of CR (n=8) (normalised peak VO2, from 75AE12 to 77AE16%), along with restored pulmonary haemodynamics (mPAP, from 24AE6 to 22AE7 mmHg). Conclusions: These results suggest that the exercise capacity recovered to near-normal levels by the combination of a series of BPA and subsequent CR is maintained even one year after the end of the CR programme in patients with inoperable CTEPH.
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Telemonitoring in patients with a new diagnosis of heart failure: from clinical research to everyday practice. G Koulaouzidis 1 , D Barrett 1 , A Clark 1 1 Castle Hill Hospital, Academic Department of Cardiology, Hull, United Kingdom Topic: Telemedicine Background: Heart failure (HF) is a complex clinical syndrome associated with high mortality and high rate of hospital readmissions. Telemonitoring (TM) is a promising strategy for improving HF outcomes but there is a need to identify those patients in whom a TM approach might provide benefit. We wanted to determine if TM in patients with recently diagnosed HF and ejection fraction <45% reduces the risk of re-admission from any cause or death from any cause in a "real world" setting. Methods: Retrospective study of 124 patients (78.2% male; aged 68.6AE12.6 years; 56.5% ischaemic etiology) who underwent TM and 345 patients (68.5% male; 70.2AE 10.7 years; 56.3% ischemic etiology) who underwent the usual-care (UC), between 2009-12. All patients had a recent diagnosis of HF, NHYA class II-III and ejection fraction <45%. The TM group were assessed daily by body weight, blood pressure and heart rate using electronic devices with automatic transfer of data to an online database. There were no differences between the two groups in the treatment with beta-blockers, ACE inhibitors/angiotensin receptor blockers and aldosterone antagonists (83%, 85%, 62% in the TM-group; 79%, 82%, 59% in the UCgroup, respectively). Follow-up was 12 months. Results: Death from any cause occurred in 8.1% of the TM-group and 19% of the UC-group, p=0.002. The TM-group and the UC-group did not differ significantly in the number of patients admitted for any cause 63.7% vs. 62.5% respectively, p=0.8. The number of readmissions/patients was also similar in the two groups, 1.3 AE 1.7 in the TM-group and 1.4 AE 1.7 in the UC-group (p=0.9). There was no difference in the number of days in hospital (8.1 AE 12.8 days in TM-group and 9.5 AE 17.3 in UC-group; p=0.4). Readmissions for HF occurred in 13.6% of patients in the TM-group and 12.7% of patients in the UC-group (p=0.9), while 0.8% of patients in the TM-group and 15.5% in the UC-group experienced admission for renal failure (p=0.0002) Readmissions for ischaemic heart disease and arrhythmias occurred in 13.6% and 12.8% in the TM-group and 17.9% and 11.5% in the UC-group, respectively. There was a significantly greater number of days alive and out of hospital for the patients in the TM-group at 348.3 AE 5.5 days compared with 329.9 AE 4.6 days in the UC-group (p=0.0001).
Conclusions:
In patients with a recent diagnosis of HF and reduced left ventricle systolic function, TM is associated with lower any-cause mortality. Furthermore TM has the potential to reduce number of days lost to hospitalization and death.
311
Cardiac rehabilitation is superior to invasive coronary revascularization in improving functional capacity as measured by cardiopulmonary exercise testing N Naresh Kumar 1 , N Kumar 1 , M Katsoulis 1 , A Bagai 2 , S Chaudhry 3 1 Whitby Cardio-Vascular, CPET Lab, WHITBY, Canada, 2 St Mikes Hospital, Toronto, Canada, 3 Met-Test, Atlanta, United States of America Topic: Cardiac rehabilitation Background: Peak VO2, peak O2-pulse (VO2/HR) and VO2 at the ventilatory anaerobic threshold (VAT) are accurate measures of cardiac function and surrogate markers of morbidity and mortality in patients with coronary artery disease (CAD). The effects of aerobic exercise on the above parameters are well documented; however, it is unknown how revascularization (REV) with percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) compares with prescribed exercise (Rehab) in its effects on functional capacity. Purpose: To compare the changes in functional capacity between cardiac rehabilitation and invasive coronary revascularization. Methodology: One hundred twenty patients with stable CAD and preserved left ventricular function were prospectively studied at a single centre. Sixty patients (51 males and 9 females, 62 AE 1 year) with confirmed CAD treated medically underwent prescribed cardiac rehabilitation with exercise on a cycle ergometer with heart rate (HR) set above the VAT and below the Ischemic Threshold observed during cardiopulmonary exercise testing (CPET). Each patient completed 3-5 supervised sessions per week (25 minutes/session) for 3 months. The other 60 patients (52 males and 8 females, 63 AE 1 year) underwent PCI (40) and CABG (20). Functional capacity was measured by CPET before and 6 AE 2 weeks after REV & 3 months after Rehab. Measurements of Peak VO2, peak O2-Pulse & VO2 at VAT were measured at rest & maximal effort of RER>1.05. Conclusions: Among patients with stable obstructive coronary artery disease, cardiac rehabilitation in the form of a prescribed exercise program is associated with improvement in functional capacity, while invasive coronary revascularization is not. ventilatory threshold (FVT) and high-intensity interval training (HIIT) (work HR= 2st VT; rest HR= FVT). The HIIT were progressively adjusted to achieve 3-min (work/rest; 1:1) (4-6 intervals). The outcomes investigated were VO2; fraction (LVEF) and mass (LVM); enzymatic and non-enzymatic OS variables. A paired t-test was used to compare the Pre-Post ET measures in each group and between groups (Adopted 5%). Results: The VO2peak increased significantly only by HIIT (21.2AE3.9 to 24.1AE4.8peak(ml/kg/min; p<0,001). The LVR exhibited a controversial result, LVEF increased significantly after HIIT (34.81 AE 6.86 to 39.75 AE8.1(%); p=0,01), while LVM diminished significantly after MCT (334,08AE97,45 to 300,27 AE95,4(gr); p<0,05). The majority of AoD variables were significantly improved by HIIT (table  1) . Conclusion: HIIT induced better adaptations in antioxidant defenses, physical fitness and left ventricular function when compared to MCT in CHF. Topic: Exercise training Background/Introduction: Endurance-type exercise, combined with adipose tissue lipolytic inhibition, stimulates intramyocellular lipid turnover and further augments the improvements in glycemic control in type 2 diabetes (T2DM) patients, at least in the first two hours after exercise. The aim of this study was to investigate the impact of adipose tissue lipolytic inhibition during endurance-type exercise on subsequent 24-hour glycemic control in T2DM patients. Methods: Fourteen male T2DM patients (age 65AE2 y, HbA1c 6.7AE0.1%) participated in a double-blind randomized cross-over study consisting of a non-exercise condition (with placebo intake), and conditions in which 60-min endurance-type exercise was executed after placebo intake or after intake of 250 mg of acipimox (niacin derivate that inhibits adipose tissue lipolysis), interspersed by one week between conditions. Blood glucose, insulin and free fatty acid (FFA) concentrations were assessed up to eight hours after exercise, from which total area under the curve (t-AUC) was calculated. On the second day of each experimental condition, subjects underwent a 2-h oral glucose tolerance test (OGTT) with assessment of blood glucose and insulin concentrations. Results: During endurance-type exercise with placebo intake, significantly greater blood FFA concentrations were registered (t-AUC 97AE7 mmol. min/L), as opposed endurance-type exercise after acipimox intake (t-AUC 40AE11 mmol. min/L) (p<0.05). Endurance-type exercise after placebo intake did not lower blood glucose (t-AUC 3946AE183 mmol*min/L) or insulin (t-AUC 14844AE1929 mIU*min/L) concentrations in the first eight hours after exercise (p>0.05) (non-exercise condition: glucose t-AUC 3794AE172 mmol*min/L, insulin t-AUC 15301AE2004 mIU*min/L, see Figure 1 ). However, as opposed to other conditions, endurance-type exercise after acipimox intake led to significant reductions in blood glucose (t-AUC 3500AE124 mmol*min/L) and insulin (t-AUC 10953AE1115 mIU*min/L) concentrations within the same timeframe (p<0.05). Glycemic control was comparable between conditions during OGTT (p>0.05).
Conclusions:
In male T2DM patients adipose tissue lipolytic inhibition during endurance-type exercise augments the improvements in glycemic control and reductions in blood insulin concentrations during the day, as opposed to endurance-type exercise alone. This approach may thus be a new therapeutic opportunity for the treatment of T2DM and should be explored further. Funding Acknowledgements: IWT-TBM grant Topic: Exercise training Background: Increase of exercise capacity after cardiac rehabilitation, as assessed by peak oxygen uptake (VO2), improves outcome in patients with coronary artery disease (CAD). Systolic and diastolic left ventricular (LV) function have been associated with peak VO2, but their role towards improvement of exercise capacity remains unclear. Furthermore, it is unknown which exercise intensity has the most beneficial impact on LV geometry and function in CAD patients without heart failure. Methods: 200 stable CAD patients without heart failure and referred for cardiac rehabilitation were randomized to 3 months of aerobic interval training (AIT) or aerobic continuous training (ACT). Patients were scheduled for a cardiopulmonary exercise test and a comprehensive transthoracic echocardiography before and after 3 months of training. Results: At baseline, a higher peak VO2 was significantly correlated with lower LV posterior wall thickness (p=0.002), higher LV ejection fraction (p=0.008), better LV global longitudinal strain (p=0.043) and lower E/e' (0=0.001). After multivariate stepwise regression analysis only E/e´remained an independent predictor of peak VO2 (p=0.042). 164 patients completed 3 month follow up. Pearson correlation analysis showed a significant correlation between improvement of peak VO2 and reverse remodeling of the interventricular septum (p=0.005), enlargement of diastolic volume (p=0.007) and increase of stroke volume (p=0.018) but not with indices of systolic or diastolic function. There was significant reduction of the interventricular septum thickness after cardiac rehabilitation (p=0.012), with a trend towards more reverse remodeling in the ACT group compared to the AIT group (p=0.054). In contrast, there were no changes in other parameters of LV geometry, diastolic or systolic function. Conclusion: Parameters of systolic and diastolic function are determinants of baseline exercise capacity in CAD patients without heart failure, but do not seem to mediate improvement of peak VO2 after either AIT or ACT. were measured using the FitMate2000 (COSMED, Rome, Italy) at discharge period. Sampling data were averaged over 30 sec intervals. Each subjects walked along a 25-m, flat, obstacle-free corridor with chairs placed at both ends at self-selected speed for 6 minutes. Subjects were instructed to walk as far as possible, turning 180 at every 25 m. Before and after the walk test, subjects sat on a chair for 3 minutes. Subjects were divided into 2 groups by 6MWD; the first group walked 300m or longer (HF-L, n = 26, 16 men), and second group walked under 300m (HF-U, n = 13, three men). The repeated measures ANOVA and Tukey method were used to compare V O2 and V E every 30sec from 30sec to 6 min during walk, and to compare the average value of 3 min before walk as resting baseline with the value of every 30sec for 3 min after walk ended as time to recovery, in each group. A P-value of <0.05 was considered significant. Approval by the institutional review board was obtained before the study was initiated, and all patients provided written informed consent to participate in the study. Results: In HF-L, V O2 (mL/kg/min) stabilized from 2 min 30 sec and in HF-U from 3 min 30 sec during walk (P < 0.01). In HF-L, V O2 recovered after 2 min 30 sec of walk test and in HF-U did not recover within 3 min (P < 0.01).With regard to V E (L/min) during walk, in HF-L was stabilized from 3 min and in HF-U from 3 min 30sec. In HF-L, V E recovered after 2 min 30sec of walk and in HF-U did not recover within 3 min (P < 0.01) (Figure 1) . Conclusion: In HF-U, a steady state and recovery of V O2 and V E were delayed in comparison with HF-L. The dynamics of V O2 and V E, both during and after walk test have differences according to 6MWD in patients with HF.
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